Ather Energy Ltd. makes a corporate announcement

QIP-only impact: Ather issued 1,08,15,307 shares, or 1.0815 Cr new shares, at ₹1,202 each for gross proceeds of ₹1,300 Cr ^[1]. The QIP increased the paid-up share capital by only ₹1.08 Cr, with the balance credited mainly to securities premium.

†Derived from the post-allotment share count/capital and the 1.0815 Cr shares issued.

Dilution: The QIP increased the share count by 2.8% versus the pre-QIP base. Since the new shares represent 2.74% of the post-QIP equity base, an investor who did not participate sees their percentage ownership reduced by approximately 2.74% on a relative basis. This is the relevant ownership dilution; the ₹1.08 Cr increase in face-value capital understates the economic size of the raise.

Book value per share

Let pre-QIP book equity be B in ₹Cr. Before issue costs:

• Pre-QIP BVPS = `B / 38.3310`
• Post-QIP BVPS = `(B + 1,300) / 39.4125`
• Equivalently, post-QIP BVPS = 97.26% of pre-QIP BVPS + ₹32.98

Therefore, the QIP is book-value accretive if the pre-QIP BVPS was below the ₹1,202 issue price, and dilutive if it was above that price. The exact immediate post-QIP BVPS cannot be confirmed without the balance-sheet book equity immediately before the July allotment.

For context, the latest reported Q2 FY27 figures show ₹4,285.8 Cr of total equity, ₹39.66 Cr of equity share capital, and ₹108.06 BVPS ^{[3] [4] [5]}. Those figures are subsequent to the QIP and later ESOP/preferential allotments, so they should not be treated as the clean pre-QIP base.

Under the stated hypothetical split of ₹1,500 Cr QIP equity + ₹1,000 Cr FCCBs treated as debt, Ather’s gross leverage would rise initially, even though the equity infusion strengthens the balance sheet. Net leverage could improve sharply only if the proceeds remain as cash. Interest coverage would weaken because the FCCB would add interest expense before conversion.

Mechanical leverage impact

Using Q2 FY27 consolidated total debt of ₹820.95 Cr, net debt of ₹456.15 Cr, debt-equity of 0.19x, debt-assets of 0.12x and net debt-to-EBITDA of 6.15x ^{[6] [7] [8] [9] [10]}:

† Equity is derived as ₹820.95 Cr divided by the reported 0.19x debt-equity ratio. ‡ Assumes deployment creates balance-sheet assets; actual debt/assets would depend on use of proceeds. All pro forma figures are derived from the reported Q2 FY27 metrics and the user-supplied ₹1,500 Cr/₹1,000 Cr funding split.

Interpretation: gross debt/equity increases to roughly 0.31x because the FCCB adds ₹1,000 Cr of debt, while equity rises by ₹1,500 Cr. However, if the full ₹2,500 Cr is initially retained as cash, net debt flips to net cash of roughly ₹1,044 Cr. If the funds are spent on capex or operating expansion, the net-deleveraging benefit largely disappears and net debt/EBITDA could rise materially.

Interest coverage before FCCB conversion

Q2 FY27 EBIT was ₹27.30 Cr and reported interest coverage was 2.85x ^{[11] [12]}. On an EBIT-based convention, this implies quarterly interest expense of approximately ₹9.58 Cr, or ₹38.3 Cr annualized.

The pre-conversion coverage formula is:

New interest coverage = ₹109.2 Cr annualized EBIT ÷ (₹38.3 Cr existing annualized interest + ₹1,000 Cr × FCCB effective interest rate)

\*Illustrative, holding Q2 FY27 EBIT constant; these are scenario calculations, not company guidance.

The key risk is therefore interest coverage rather than balance-sheet solvency alone. At an 8-10% effective FCCB cost, coverage would fall below 1.0x on the Q2 EBIT run-rate, leaving little operating buffer until profitability expands.

On conversion, the ₹1,000 Cr FCCB liability would move into equity, reducing gross debt/equity mechanically to approximately 0.12x, assuming no other balance-sheet changes. That would remove the FCCB interest burden but create additional equity dilution.

Important scope point: the board approved up to ₹1,500 Cr through QIP and up to ₹1,000 Cr through equity shares, FCCBs or other convertibles—not necessarily ₹1,000 Cr of FCCBs ^{[13] [13]}. Moreover, the QIP subsequently raised ₹1,300 Cr ^[2]. Therefore, the calculations above are a requested debt-treatment scenario applied to the reported Q2 FY27 baseline, not a confirmed final capital-structure bridge.

The R&D, manufacturing-capacity and working-capital split cannot be confirmed from the cited QIP Objects section. The available QIP filing extract confirms only that the issue size was ₹1,300 Cr; it does not provide a line-by-line allocation across those three uses. ^[14]

The closest disclosed allocation is from Ather’s separate preferential issue, not the QIP:

Operational bridge: the stated next milestone was Phase-I commencement of Factory 3.0 in Q3 FY27, adding 5 lakh units of capacity, within a planned 10 lakh-unit total capacity across Phase I and Phase II. ^[18] The QIP was reported as being raised to fund manufacturing expansion, so its strategic role was to provide liquidity ahead of this capacity ramp. ^[19] However, without the QIP’s specific R&D, capex and working-capital allocations—or confirmed utilization by milestone—the funding cannot be quantitatively mapped to the Factory 3.0 investment requirement. The defensible conclusion is therefore directional: the QIP was intended to support the transition to Factory 3.0, but the disclosed evidence does not establish how much of the ₹1,300 Cr was earmarked for each component or whether it fully bridges the milestone’s funding gap.